Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385525493> ?p ?o ?g. }
- W4385525493 endingPage "1280" @default.
- W4385525493 startingPage "1280" @default.
- W4385525493 abstract "Among the pathogenic free-living amoebae (FLA), Naegleria fowleri is the etiological agent of a fatal disease known as primary amoebic meningoencephalitis (PAM). Once infection begins, the lesions generated in the central nervous system (CNS) result in the onset of symptoms leading to death in a short period of time. Currently, there is no standardized treatment against the infection, which, due to the high virulence of the parasite, results in a high case fatality rate (>97%). Therefore, it is essential to search for new therapeutic sources that can generate a rapid elimination of the parasite. In recent years, there have already been several successful examples of drug repurposing, such as Nitroxoline, for which, in addition to its known bioactive properties, anti-Balamuthia activity has recently been described. Following this approach, the anti-Naegleria activity of Nitroxoline was tested. Nitroxoline displayed low micromolar activity against two different strains of N. fowleri trophozoites (IC50 values of 1.63 ± 0.37 µM and 1.17 ± 0.21 µM) and against cyst stages (IC50 of 1.26 ± 0.42 μM). The potent anti-parasitic activity compared to the toxicity produced (selectivity index of 3.78 and 5.25, respectively) in murine macrophages and human cell lines (reported in previous studies), together with the induction of programmed cell death (PCD)-related events in N. fowleri make Nitroxoline a great candidate for an alternative PAM treatment." @default.
- W4385525493 created "2023-08-04" @default.
- W4385525493 creator A5026517592 @default.
- W4385525493 creator A5034000875 @default.
- W4385525493 creator A5037164382 @default.
- W4385525493 creator A5039128843 @default.
- W4385525493 creator A5063263007 @default.
- W4385525493 creator A5066013679 @default.
- W4385525493 creator A5069010044 @default.
- W4385525493 date "2023-08-03" @default.
- W4385525493 modified "2023-10-17" @default.
- W4385525493 title "Repurposing of Nitroxoline as an Alternative Primary Amoebic Meningoencephalitis Treatment" @default.
- W4385525493 cites W1599366903 @default.
- W4385525493 cites W1966245361 @default.
- W4385525493 cites W1975287400 @default.
- W4385525493 cites W2007226778 @default.
- W4385525493 cites W2019316774 @default.
- W4385525493 cites W2020037351 @default.
- W4385525493 cites W2029502145 @default.
- W4385525493 cites W2050009796 @default.
- W4385525493 cites W2053022803 @default.
- W4385525493 cites W2063039714 @default.
- W4385525493 cites W2076598575 @default.
- W4385525493 cites W2100323398 @default.
- W4385525493 cites W2115772647 @default.
- W4385525493 cites W2135467238 @default.
- W4385525493 cites W2137245547 @default.
- W4385525493 cites W2143587535 @default.
- W4385525493 cites W2166142704 @default.
- W4385525493 cites W2173889361 @default.
- W4385525493 cites W2181019606 @default.
- W4385525493 cites W2331371410 @default.
- W4385525493 cites W2336732132 @default.
- W4385525493 cites W2482779188 @default.
- W4385525493 cites W2560809684 @default.
- W4385525493 cites W2565966602 @default.
- W4385525493 cites W2736762943 @default.
- W4385525493 cites W2765712927 @default.
- W4385525493 cites W2792658913 @default.
- W4385525493 cites W2793919752 @default.
- W4385525493 cites W2884454099 @default.
- W4385525493 cites W2898801233 @default.
- W4385525493 cites W2922586999 @default.
- W4385525493 cites W2948530572 @default.
- W4385525493 cites W2968055765 @default.
- W4385525493 cites W2980845752 @default.
- W4385525493 cites W3020198860 @default.
- W4385525493 cites W3046330329 @default.
- W4385525493 cites W3046597137 @default.
- W4385525493 cites W3197618439 @default.
- W4385525493 cites W4200380688 @default.
- W4385525493 cites W4223538408 @default.
- W4385525493 cites W4224222954 @default.
- W4385525493 cites W4280610258 @default.
- W4385525493 cites W4282046378 @default.
- W4385525493 cites W4285005090 @default.
- W4385525493 cites W4294834006 @default.
- W4385525493 cites W4313236799 @default.
- W4385525493 cites W4376127507 @default.
- W4385525493 doi "https://doi.org/10.3390/antibiotics12081280" @default.
- W4385525493 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37627700" @default.
- W4385525493 hasPublicationYear "2023" @default.
- W4385525493 type Work @default.
- W4385525493 citedByCount "0" @default.
- W4385525493 crossrefType "journal-article" @default.
- W4385525493 hasAuthorship W4385525493A5026517592 @default.
- W4385525493 hasAuthorship W4385525493A5034000875 @default.
- W4385525493 hasAuthorship W4385525493A5037164382 @default.
- W4385525493 hasAuthorship W4385525493A5039128843 @default.
- W4385525493 hasAuthorship W4385525493A5063263007 @default.
- W4385525493 hasAuthorship W4385525493A5066013679 @default.
- W4385525493 hasAuthorship W4385525493A5069010044 @default.
- W4385525493 hasBestOaLocation W43855254931 @default.
- W4385525493 hasConcept C104317684 @default.
- W4385525493 hasConcept C159047783 @default.
- W4385525493 hasConcept C2777752497 @default.
- W4385525493 hasConcept C2778621254 @default.
- W4385525493 hasConcept C2781155112 @default.
- W4385525493 hasConcept C54355233 @default.
- W4385525493 hasConcept C55493867 @default.
- W4385525493 hasConcept C60987743 @default.
- W4385525493 hasConcept C71924100 @default.
- W4385525493 hasConcept C81885089 @default.
- W4385525493 hasConcept C86803240 @default.
- W4385525493 hasConcept C89423630 @default.
- W4385525493 hasConceptScore W4385525493C104317684 @default.
- W4385525493 hasConceptScore W4385525493C159047783 @default.
- W4385525493 hasConceptScore W4385525493C2777752497 @default.
- W4385525493 hasConceptScore W4385525493C2778621254 @default.
- W4385525493 hasConceptScore W4385525493C2781155112 @default.
- W4385525493 hasConceptScore W4385525493C54355233 @default.
- W4385525493 hasConceptScore W4385525493C55493867 @default.
- W4385525493 hasConceptScore W4385525493C60987743 @default.
- W4385525493 hasConceptScore W4385525493C71924100 @default.
- W4385525493 hasConceptScore W4385525493C81885089 @default.
- W4385525493 hasConceptScore W4385525493C86803240 @default.
- W4385525493 hasConceptScore W4385525493C89423630 @default.
- W4385525493 hasFunder F4320324671 @default.